Abstract
BACKGROUND
Peripheral arterial disease is a major cause of the development of diabetic foot ulcers, lower limb amputation and mortality in patients with diabetes. Diagnosing peripheral arterial disease is of clinical importance but is difficult in this cohort of patients. Several diagnostic bedside tests exist, but there is uncertainty as to which is the most accurate.
OBJECTIVE(S)
To determine the diagnostic accuracy of five index tests (audible waveform assessment, visual waveform assessment, toe-brachial pressure index, ankle-brachial pressure index and exercise ankle-brachial pressure index) for the diagnosis of peripheral arterial disease in patients with diabetes as determined by a reference test (computed tomography angiography or magnetic resonance angiography). In selected sites, to evaluate the performance of a sixth test, the Podiatry Ankle Duplex scan, a new point-of-care duplex ultrasound scan.
DESIGN AND METHODS
Prospective multicentre diagnostic accuracy study.
SETTING
Primary (general practice and community clinics) and secondary care National Health Service hospitals (inpatient and outpatient) in the United Kingdom.
PARTICIPANTS
Patients were eligible for inclusion if they were aged ≥ 18 years and had a known history of diabetes. Exclusion criteria included contraindications to computed tomography angiography or magnetic resonance angiography, if their peripheral arterial disease status was known on imaging, or they had a known history of peripheral arterial disease intervention.
INTERVENTIONS
Participants underwent all bedside tests (Podiatry Ankle Duplex scan performed in three centres only), which were performed in a logical sequence to reduce the risk of bias. The reference scan was to be performed within 6 weeks of the index tests.
MAIN OUTCOME MEASURES
The primary outcome measure of diagnostic performance is test sensitivity. Secondary outcomes included specificity, likelihood ratios, predictive values and diagnostic odds ratio, as well as patient acceptability of tests, technical success and health economic outcomes.
RESULTS
Based on the 573 reference tests performed, 222 (39%) participants had evidence of peripheral arterial disease. All routinely used index tests showed relatively low sensitivities: audible waveform 36%, 99% confidence interval 27% to 45%; visual waveform 42%, confidence interval 33% to 51%; toe-brachial pressure index 55%, confidence interval 46% to 64%; ankle-brachial pressure index 41%, confidence interval 32% to 50%; and exercise ankle-brachial pressure index 41%, confidence interval 31% to 51%. The Podiatry Ankle Duplex scan had a higher sensitivity 89%, confidence interval 74% to 100%, as compared to all other index tests.
LIMITATIONS
A large proportion of reference scans were performed outside the 6-week time window (45%), although peripheral arterial disease is a chronic condition and is unlikely to have developed/progressed in the time frame. Additionally, the peripheral arterial disease prevalence was lower than anticipated during study design (39% vs. 50%). Lastly, despite efforts to standardise assessment and minimise bias, there is the possibility that one test may have influenced the interpretation of others.
CONCLUSIONS
Index tests used routinely in clinical practice for diagnosing peripheral arterial disease in patients with diabetes showed poor diagnostic accuracy for peripheral arterial disease and should not be recommended for diagnosing peripheral arterial disease in this population.
FUTURE WORK
A review of peripheral arterial disease diagnostic testing in patients with diabetes should be undertaken. It may be necessary to perform more reliable imaging, such as full lower limb duplex ultrasound as a first-line diagnostic test.
FUNDING
This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR131855.
Plain language summary
The detection of poor circulation, known as peripheral arterial disease, in patients with diabetes is difficult. A number of tests exist to detect peripheral arterial disease, however, there is confusion as to which is the gold standard. The DM peripheral arterial disease study determined the diagnostic performance of a number of bedside tests for the diagnosis of peripheral arterial disease in patients with diabetes. Six hundred and four patients with a known history of diabetes at 16 primary and secondary National Health Service centres in the United Kingdom took part. Bedside tests (audible hand-held Doppler, visual hand-held Doppler, blood pressure measurements at the arm and ankle, blood pressure measurements at the arm and ankle following repetitive heel raises and blood pressure measurements at the big toe) for the diagnosis of peripheral arterial disease in patients with diabetes were compared to reference tests (computed tomography angiography or magnetic resonance angiography scan). Each of the five routinely used bedside tests showed low sensitivities. Overall, none of the tests demonstrated an acceptable combination of sensitivity or specificity. Combining different tests together did improve sensitivities, but many cases of peripheral arterial disease were still missed (confirmed via the reference scan). Future work may involve a review of how peripheral arterial disease is diagnosed in patients with diabetes. It may be necessary to bypass bedside tests in favour of more reliable imaging, such as full lower limb duplex ultrasound.
Full text of this article can be found in Bookshelf.
References
- Ince P, Abbas ZG, Lutale JK, Basit A, Ali SM, Chohan F, et al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care 2008;31:964–7. doi: 10.2337/dc07-2367. [DOI] [PubMed]
- Stoberock K, Kaschwich M, Nicolay SS, Mahmoud N, Heidemann F, Rieß HC, et al. The interrelationship between diabetes mellitus and peripheral arterial disease. Vasa 2020;50:323–30. doi: 10.1024/0301-1526/a000925. [DOI] [PubMed]
- Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007;50:18–25. doi: 10.1007/s00125-006-0491-1. [DOI] [PubMed]
- The Information Centre for Health and Social Care. National Diabetes Foot Care Report. April 2022. URL: https://fingertips.phe.org.uk/static-reports/diabetes-footcare/national-diabetic-footcare-report.html (accessed 13 December 2024).
- National Institute for Health and Care Excellence (NICE). Peripheral Arterial Disease: Diagnosis and Management. Evidence Review for Determining Diagnosis and Severity of PAD in People with Diabetes. London: NICE; 2018. [PubMed]
- Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, Katsanos K, et al. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review. Diabetes Metab Res Rev 2020;36:e3277. doi: 10.1002/dmrr.3277. [DOI] [PubMed]
- Normahani P, Mustafa C, Shalhoub J, Davies AH, Norrie J, Sounderajah V, et al. A systematic review and meta-analysis of the diagnostic accuracy of point-of-care tests used to establish the presence of peripheral arterial disease in people with diabetes. J Vasc Surg 2021;73:1811–20. doi: 10.1016/j.jvs.2020.11.030. [DOI] [PubMed]
- Normahani P, Poushpas S, Alaa M, Bravis V, Aslam M, Jaffer U. Study protocol for a comparative diagnostic accuracy study of bedside tests used to detect arterial disease in diabetes: TEsting for Arterial disease in Diabetes (TrEAD) study. BMJ Open 2020;10:e033753. doi: 10.1136/bmjopen-2019-033753. [DOI] [PMC free article] [PubMed]
- Normahani P, Poushpas S, Alaa M, Bravis V, Sounderajah V, Aslam M, Jaffer U. Diagnostic accuracy of point-of-care tests used to detect arterial disease in diabetes: testing for arterial disease in diabetes (TrEAD) study. Ann Surg 2022;276:e605–12. doi: 10.1097/SLA.0000000000004545. [DOI] [PubMed]
- Normahani P, Burgess L, Norrie J, Epstein DM, Kandiyil N, Athanasios S, et al. Study protocol for a multicentre comparative diagnostic accuracy study of tools to establish the presence and severity of peripheral arterial disease in people with diabetes mellitus: the DM PAD study. BMJ Open 2022;12:e066950. https://doi.org/10.1136/bmjopen-2022-066950 doi: 10.1136/bmjopen-2022-066950. [DOI] [PMC free article] [PubMed]
- Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317–24. doi: 10.1001/jama.286.11.1317. [DOI] [PubMed]
- Mills JL Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220–34.e2. doi: 10.1016/j.jvs.2013.08.003. [DOI] [PubMed]
- McPhail IR, Spittell PC, Weston SA, Bailey KR. Intermittent claudication: an objective office-based assessment. J Am Coll Cardiol 2001;37:1381–5. doi: 10.1016/s0735-1097(01)01120-2. [DOI] [PubMed]
- Eiberg JP, Rasmussen JG, Hansen MA, Schroeder TV. Duplex ultrasound scanning of peripheral arterial disease of the lower limb. Eur J Vasc Endovasc Surg 2010;40:507–12. doi: 10.1016/j.ejvs.2010.06.002. [DOI] [PubMed]
- Diehm N, Shang A, Silvestro A, Do DD, Dick F, Schmidli J, et al. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovasc Surg 2006;31:59–63. doi: 10.1016/j.ejvs.2005.09.006. [DOI] [PubMed]
- Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 2010;153:325–34. doi: 10.7326/0003-4819-153-5-201009070-00007. [DOI] [PubMed]
- Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301:415–24. doi: 10.1001/jama.301.4.415. [DOI] [PubMed]
- Morris D, Singh T, Moxon J, Smith A, Stewart F, Jones R, et al. Assessment and validation of a novel angiographic scoring system for peripheral artery disease. J Br Surg 2017;104:544–54. doi: 10.1002/bjs.10460. [DOI] [PubMed]
- Staniszewska S, Jones N, Newburn M, Marshall S. User involvement in the development of a research bid: barriers, enablers and impacts 1. Health Expect 2007;10:173–83. doi: 10.1111/j.1369-7625.2007.00436.x. [DOI] [PMC free article] [PubMed]
- Roberts L, Turner K, George S, Ward D. Briefing Notes for Researchers: Public Involvement in NHS, Public Health and Social Care Research. NIHR; 2020.
- Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ 2017;358:j3453. doi: 10.1136/bmj.j3453. [DOI] [PMC free article] [PubMed]
- Amirhamzeh M, Chant H, Rees J, Hands L, Powell R, Campbell W. A comparative study of treadmill tests and heel raising exercise for peripheral arterial disease. Eur J Vasc Endovasc Surg 1997;13:301–5. doi: 10.1016/s1078-5884(97)80102-5. [DOI] [PubMed]
- Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al.; American Heart Association Council on Peripheral Vascular Disease. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012;126:2890–909. doi: 10.1161/CIR.0b013e318276fbcb. [DOI] [PubMed]
- NIHR BAME Participation Toolkit. URL: https://arc-nenc.nihr.ac.uk/resources/toolkit-for-increasing-participation-of-bame-groups-in-health-and-social-care-research/ (accessed 13 December 2024).
